The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective

Diabetes Research and Clinical Practice
Jian-Jun LiuSu Chi Lim

Abstract

Fibroblast growth factor 21 (FGF21) has been well-recognized as a metabolic hormone and a promising target for treatment of metabolic diseases. The level of endogenous FGF21 is elevated in patients with impaired glucose tolerance and progressively increased from patients with overt type 2 diabetes to those with micro- and macro-vascular complications, presumably as a compensation or response to the deterioration of metabolic imbalance. A few exploratory in vivo studies, including a recent clinical trial, showed that exogenous FGF21 mimetics targeting FGF21 signaling can attain beneficial metabolic effects not with-standing the already elevated ambient FGF21 levels. In addition, some clinically available pharmacologic agents such as fenofibrates and metformin may modulate energy and macronutrients metabolism by acting through FGF21. This review mainly focuses on the role of FGF21 in development, progression and treatment of type 2 diabetes from a clinical perspective.

References

Jun 20, 2000·Biochimica Et Biophysica Acta·T NishimuraN Itoh
Feb 19, 2004·JAMA : the Journal of the American Medical Association·Mike Mitka
May 20, 2005·The Journal of Clinical Investigation·Alexei KharitonenkovArmen B Shanafelt
Jul 1, 2008·Cell Metabolism·Takeshi InagakiSteven A Kliewer
Oct 9, 2008·Diabetes Care·Sebastian SteinMathias Fasshauer
Aug 25, 2009·Metabolism: Clinical and Experimental·Sebastian SteinMathias Fasshauer
Apr 29, 2010·American Journal of Physiology. Endocrinology and Metabolism·Knut MaiJoachim Spranger
May 11, 2010·Diabetes Research and Clinical Practice·Kazuhiro EtoShun Ishibashi
Aug 5, 2010·Diabetes·Ffolliott M FisherEleftheria Maratos-Flier
Dec 3, 2010·The Journal of Clinical Endocrinology and Metabolism·Henna TyynismaaKirsi H Pietiläinen
Oct 21, 2011·The Journal of Clinical Endocrinology and Metabolism·Yang XiaoKaren S L Lam
Dec 6, 2011·Metabolism: Clinical and Experimental·Wei-Xia JianQing Su
Dec 17, 2011·Science Translational Medicine·Ai-Luen WuJunichiro Sonoda
Feb 7, 2012·Cell·Li Qiang, Domenico Accili
Apr 13, 2012·Journal of the American Geriatrics Society·Candace CrastoLuigi Ferrucci
Apr 25, 2012·European Journal of Endocrinology·Sara G VienbergBirgitte Andersen
May 17, 2012·Current Diabetes Reviews·A C Adams, A Kharitonenkov
Jul 18, 2012·Annals of Internal Medicine·Michael S Lauer
Nov 3, 2012·Experimental Diabetes Research·Eva B NygaardBirgitte Andersen
Nov 9, 2012·Clinical Endocrinology·Y C WooKaren S L Lam
Nov 13, 2012·The Journal of Clinical Endocrinology and Metabolism·Kwok Leung OngUNKNOWN FIELD study investigators
Dec 5, 2012·PloS One·Andrew C AdamsAlexei Kharitonenkov
Feb 20, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M StrączkowskiA Nikołajuk
Mar 29, 2013·PloS One·Alexei KharitonenkovDavid E Moller
May 15, 2013·Cell Metabolism·William L HollandPhilipp E Scherer
Jun 19, 2013·Nature Reviews. Nephrology·Makoto Kuro-o

❮ Previous
Next ❯

Citations

Sep 29, 2015·Molecular Metabolism·Leon Straub, Christian Wolfrum
Sep 3, 2016·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Nicole E BrooksDarlene E Berryman
Oct 12, 2016·Bone·Christian Faul
Apr 1, 2018·Molecular Nutrition & Food Research·Jie YinYulong Yin
Jun 30, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Maria ConteStefano Salvioli
Jan 17, 2019·Current Drug Targets·Hassan Dianat-Moghadam, Ladan Teimoori-Toolabi
Oct 5, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Tahseen A Chowdhury, Paul Grant
Jan 19, 2016·Current Opinion in Lipidology·Peter CliftonJennifer Keogh
Feb 27, 2020·International Journal of Molecular Sciences·Zhongjie FuLois E H Smith
Aug 7, 2020·Seminars in Immunopathology·Maria ConteStefano Salvioli
Nov 6, 2020·American Journal of Physiology. Cell Physiology·Saima AjazKosh Agarwal
Feb 23, 2021·Metabolism: Clinical and Experimental·João Victor SalgadoNatalino Salgado Filho
Apr 1, 2021·Experimental & Molecular Medicine·Yo Na KimJe Kyung Seong
Jul 31, 2021·European Journal of Nutrition·Zhen DongJohn P Richie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.